Technical Analysis for GBT - Global Blood Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
GBT closed up 4.17 percent on Thursday, August 16, 2018, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Up||Up||Up|
|See historical GBT trend table...|
|Date||Alert Name||Type||% Chg|
|Aug 16||Stochastic Reached Overbought||Strength||0.00%|
|Aug 16||Multiple of Ten Bearish||Other||0.00%|
|Aug 16||Above Upper BB||Strength||0.00%|
|Aug 16||Overbought Stochastic||Strength||0.00%|
|Aug 16||Up 3 Days in a Row||Strength||0.00%|
|Aug 16||Upper Bollinger Band Touch||Strength||0.00%|
|Aug 15||Upside 200 DMA Break||Bullish||4.17%|
|Aug 15||Outside Day||Range Expansion||4.17%|
|Aug 13||Down 3 Days in a Row||Weakness||10.63%|
|Aug 13||Down 4 Days in a Row||Weakness||10.63%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more GBT news...
|52 Week High||68.05|
|52 Week Low||26.1|
|200-Day Moving Average||47.0727|
|50-Day Moving Average||43.621|
|20-Day Moving Average||44.4475|
|10-Day Moving Average||46.805|
|Average True Range||2.4783|
|Chandelier Exit (Long, 3 ATRs )||44.2651|
|Chandelier Exit (Short, 3 ATRs )||47.2849|
|Upper Bollinger Band||49.6997|
|Lower Bollinger Band||39.1953|
|Percent B (%b)||1.02|
|MACD Signal Line||0.8127|
|Market Cap||2.18 Billion|
|Num Shares||43.7 Million|
|Price-to-Earnings (P/E) Ratio||-20.30|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||55.73|
|Resistance 3 (R3)||55.67||53.68||54.76|
|Resistance 2 (R2)||53.68||52.21||53.71||54.44|
|Resistance 1 (R1)||51.82||51.30||52.75||51.88||54.12|
|Support 1 (S1)||47.97||48.36||48.90||48.03||45.78|
|Support 2 (S2)||45.98||47.45||46.01||45.46|
|Support 3 (S3)||44.12||45.98||45.14|
|Support 4 (S4)||44.18|